By David Woods (david.woods@rxcomms.com) While the Golden Age of the pharmaceutical industry is over, and its reputation similar to that of the tobacco and oil industries, there is hope at…
By David Woods (david.woods@rxcomms.com) The pharmaceutical industry is too often blamed for the stratospheric costs of healthcare — particularly in the United States. Yet, according to a series of surveys…
Recent reports in the Wall Street Journal and The Economist describe an imminent seismic shift in business models for pharmaceutical companies, as current blockbuster drugs are set to go off-patent and a rapidly dwindling pipeline of new drugs are under development or are being reviewed for approval.
By David Woods (david.woods@rxcomms.com) Newly-installed ISPOR president Diana Brixner, RPh, PhD, has put together a challenging agenda for the society during her term of office. The central point of that…
Health Outcomes Communicator is starting a regular series describing the major drug approval agencies and healthcare systems in countries across the world. In this first article, we’ll start with two of the largest drug approval agencies – the Food and Drug Administration in the United States (US FDA) and the European Medicines Evaluation Agency (EMEA).
Once you have made a shortlist of no more than five agencies, ask each of them to present themselves and/or ‘pitch’ for a particular project. This is your chance to pick the right agency for the job, based on what you see and what you hear.
By Clare Gurton There are hundreds of healthcare agencies and trying to find one that will suit your needs is difficult and potentially time-consuming. The key is to limit your…
